Dementia is a clinical and public health issue of growing importance a
s life expectancy increases across the planet. Despite advances in bot
h genetic research and clinical management strategies, neither cure no
r primary prevention is currently feasible. However, screening for dem
entia is critical for secondary prevention, i.e., early diagnosis and
treatment as well as disability limitation and prevention of complicat
ions. Screening is also important for community surveillance and the p
lanning of health and human services. The most appropriate screening a
pproach for a particular clinical or research setting should be select
ed on the basis of the purpose of screening in that setting. Ideally,
all elderly individuals, as well as younger persons with known risk fa
ctors, should be routinely screened for dementia. Availability of staf
f resources, including time and skills, should also be taken into acco
unt. Objective cognitive testing appears to be the most logical approa
ch to screening for dementia. However, potential confounding variables
and psychometric properties of the instruments should be considered.
Ancillary measures such as functional disability scales, self-reported
cognitive functioning, and informants' perceptions may usefully suppl
ement (or supplant) cognitive testing in certain populations. The limi
tations of screening should be recognized.